<DOC>
	<DOCNO>NCT00501904</DOCNO>
	<brief_summary>Metformin , oral biguanide administrate treat type-2 diabetes mellitus , safe effective drug recently experiment also patient polycystic ovary syndrome ( PCOS ) . The administration metformin induces ovulatory cycle CC-resistant -nonresistant patient PCOS , improve ovulation rate additional treatment woman receive CC . To date , unknown best protocol metformin administration . In particular , know long patient ovulate metformin continue treatment switch second-line ovulation induction therapy . In regard , recent study Kaplan-Meier survival analysis demonstrate first pregnancy occur late metformin estimate median seven month . Based consideration , aim present study evaluate clinical efficacy metformin accord duration administration infertile PCOS patient ovulate treatment .</brief_summary>
	<brief_title>Metformin Infertile PCOS Patients</brief_title>
	<detailed_description>Infertile PCOS patient three ovulatory cycle metformin , administer use tailor protocol , enrol randomize two group ( group A B ) . Patients group A continue metformin administration three cycle follow six month progestogens cyclically administer , whereas patient group B continue metformin therapy nine cycle . All patient eligible undergo baseline assessment consist anthropometric , hormonal , ultrasonographic evaluation . During study , clinical reproductive outcome , adverse experience evaluate patient . Data analyze use intention-to-treat principle P value 0.05 less consider significant . Continuous variable analyze unpaired test general linear model repeat measure analysis Bonferroni test post-hoc analysis require . For categorical variable , Pearson chi-square Fisher 's exact test use . Cumulative pregnancy rate , primary end-point , calculate Kaplan-Maier method , difference two group assess log-rank test . Cox proportional-hazards model use calculate hazard ratio new pregnancy group .</detailed_description>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Polycystic ovary syndrome ( use NIH criterion ) Anovulatory infertility ( use WHO criterion ) Ovulatory cycle metformin ( three cycle ) Age &lt; 18 &gt; 35 year Severe obesity ( BMI &gt; 35 ) Neoplastic , metabolic , hepatic , cardiovascular disorder concurrent medical illness Hypothyroidism , hyperprolactinemia , Cushing 's syndrome , nonclassical congenital adrenal hyperplasia Current previous ( within last six month ) use oral contraceptive , glucocorticoid , antiandrogens , antidiabetic antiobesity drug hormonal drugsPrevious use ovulation induction agent Intention start diet specific program physical activity Organic pelvic diseases Previous pelvic surgery Suspected peritoneal factor infertility Tubal male factor infertility subfertility</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Anovulation</keyword>
	<keyword>Infertility</keyword>
	<keyword>Metformin</keyword>
	<keyword>PCOS</keyword>
	<keyword>Treatment</keyword>
</DOC>